Predictors and empiric anti-microbial therapy of late-onset sepsis in the neonatal intensive care unit

Keyphrases

• Amphotericin B 10%
• Antimicrobial Therapy 40%
• Apnea 20%
• Birth Weight 10%
• Bradycardia 20%
• Candida 10%
• Causative Pathogen 20%
• Clinical Laboratory 10%
• Clinical Signs 20%
• Coagulase-negative Staphylococci (CoNS) 20%
• CSF Production 10%
• Demographic Characteristics 10%
• Empiric Antimicrobial Therapy 100%
• Fungi 10%
• Imipenem 10%
• Klebsiella 20%
• Laboratory Abnormalities 10%
• Late-onset Sepsis 100%
• Logistic Regression 10%
• Low Birth Weight 10%
• Medical Records 10%
• Microbiological Data 20%
• Multivariate Analysis 10%
• Neonatal Diagnosis 10%
• Neonatal Intensive Care Unit 100%
• Neonatal Intervention 10%
• Neonate 20%
• Perinatal Characteristics 10%
• Platelet Count 10%
• Positive Blood Culture 10%
• Sepsis 20%
• Sepsis Workup 20%
• Significant Predictors 10%
• Thrombocytopenia 10%
• Urine Culture 10%
• Vancomycin 10%

Medicine and Dentistry

• Amphotericin B 7%
• Antimicrobial Therapy 100%
• Apnea 15%
• Birth Weight 7%
• Blood Culture 7%
• Cerebrospinal Fluid 7%
• Clinical Intervention 7%
• Coagulase Negative Staphylococcus 15%
• Imipenem 7%
• Klebsiella 15%
• Low Birth Weight 7%
• Medical Record 7%
• Multivariate Logistic Regression Analysis 7%
• Neonatal Intensive Care Unit 100%
• Neonatal Sepsis 7%
• Neonate 15%
• Pathogen 15%
• Platelet 7%
• Population Research 7%
• Sepsis 100%
• Thrombocytopenia 7%
• Urine Culture 7%
• Vancomycin 7%

Pharmacology, Toxicology and Pharmaceutical Science

• Imipenem 7%